Skip to main content

Table 3 Multivariant analysis of effects on overall survival stratified by residual disease after primary surgery.

From: Weekly induction intraperitoneal chemotherapy after primary surgical cytoreduction in patients with advanced epithelial ovarian cancer

Variable Harzard 95%CI P value
Age >60 1.26 1.02–1.57 0.03
FIGO stage IV 4.84 2.73–8.57 <0.01
Initial paclitaxel* 0.80 0.71–0.90 <0.01
IP chemotherapy 0.71 0.56–0.90 <0.01
  1. Abbreviation: IP, intraperitoneal; 95%CI, 95% confidential interval; FIGO, International Federation of Gynecology and Obstetrics.
  2. * Paclitaxel as front-line chemotherapy.